Cargando…
Interleukin-35 modulates the balance between viral specific CD4(+)CD25(+)CD127(dim/-) regulatory T cells and T helper 17 cells in chronic hepatitis B virus infection
BACKGROUND: Interleukin (IL)-35 regulates imbalance between regulatory T cells (Tregs) and T helper (Th) 17 cells, leading to an important modulator in autoimmune disorder, cancer, and infectious diseases. Our previous study revealed an immunosuppressive activity of IL-35 in chronic hepatitis B viru...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469219/ https://www.ncbi.nlm.nih.gov/pubmed/30992023 http://dx.doi.org/10.1186/s12985-019-1158-0 |
_version_ | 1783411603290456064 |
---|---|
author | Yang, Lanlan Jia, Shengnan Shao, Xue Liu, Siqi Zhang, Qian Song, Jie Wang, Wudong Jin, Zhenjing |
author_facet | Yang, Lanlan Jia, Shengnan Shao, Xue Liu, Siqi Zhang, Qian Song, Jie Wang, Wudong Jin, Zhenjing |
author_sort | Yang, Lanlan |
collection | PubMed |
description | BACKGROUND: Interleukin (IL)-35 regulates imbalance between regulatory T cells (Tregs) and T helper (Th) 17 cells, leading to an important modulator in autoimmune disorder, cancer, and infectious diseases. Our previous study revealed an immunosuppressive activity of IL-35 in chronic hepatitis B virus (HBV) infection. Thus, the aim of the current study was to investigate the role of regulatory function of IL-35 to viral specific Tregs/Th17 cells balance in chronic HBV infection. METHODS: A total of 44 HLA-A2 restricted chronic HBV infected patients, including 21 of chronic hepatitis B (CHB) and 23 of asymptomatic HBV carriers (ASC) were enrolled. Purified CD4(+) T cells or CD4(+)CD25(+)CD127(dim/−) Tregs were stimulated with recombinant IL-35. HBV core antigen specific Tregs and Th17 cells were determined by flow cytometry. FoxP3 and RORγt mRNA was measured by real-time PCR. Cytokines production (IL-10 and IL-17) was investigated by ELISA. RESULTS: Peripheral viral specific Tregs was comparable between CHB and ASC. However, increased percentage of viral specific Th17 cells was found in CHB, leading to the reduction of Tregs/Th17 ratio in CHB patients. IL-35 stimulation elevated viral specific Tregs, but not Th17 cells frequency, in both CHB and ASC, resulting in the elevation of Tregs/Th17 ratio in both groups. This process was accompanied by increased expression of FoxP3 mRNA and IL-10 production, and decreased IL-17 secretion and STAT3 phosphorylation in purified CD4(+) T cells. Moreover, IL-35 stimulation inhibited viral specific Th17-like phenotype differentiation from Tregs in CHB patients. Effective anti-HBV therapy did not affect viral specific Tregs/Th17 cells frequency or IL-35 expression in CHB patients, however, reduced responsiveness of CD4(+) T cells or Tregs to IL-35 stimulation in vitro. CONCLUSION: Our findings indicated that IL-35 regulation to viral specific Tregs/Th17 balance may contribute to viral persistence in chronic HBV infection. |
format | Online Article Text |
id | pubmed-6469219 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-64692192019-04-24 Interleukin-35 modulates the balance between viral specific CD4(+)CD25(+)CD127(dim/-) regulatory T cells and T helper 17 cells in chronic hepatitis B virus infection Yang, Lanlan Jia, Shengnan Shao, Xue Liu, Siqi Zhang, Qian Song, Jie Wang, Wudong Jin, Zhenjing Virol J Research BACKGROUND: Interleukin (IL)-35 regulates imbalance between regulatory T cells (Tregs) and T helper (Th) 17 cells, leading to an important modulator in autoimmune disorder, cancer, and infectious diseases. Our previous study revealed an immunosuppressive activity of IL-35 in chronic hepatitis B virus (HBV) infection. Thus, the aim of the current study was to investigate the role of regulatory function of IL-35 to viral specific Tregs/Th17 cells balance in chronic HBV infection. METHODS: A total of 44 HLA-A2 restricted chronic HBV infected patients, including 21 of chronic hepatitis B (CHB) and 23 of asymptomatic HBV carriers (ASC) were enrolled. Purified CD4(+) T cells or CD4(+)CD25(+)CD127(dim/−) Tregs were stimulated with recombinant IL-35. HBV core antigen specific Tregs and Th17 cells were determined by flow cytometry. FoxP3 and RORγt mRNA was measured by real-time PCR. Cytokines production (IL-10 and IL-17) was investigated by ELISA. RESULTS: Peripheral viral specific Tregs was comparable between CHB and ASC. However, increased percentage of viral specific Th17 cells was found in CHB, leading to the reduction of Tregs/Th17 ratio in CHB patients. IL-35 stimulation elevated viral specific Tregs, but not Th17 cells frequency, in both CHB and ASC, resulting in the elevation of Tregs/Th17 ratio in both groups. This process was accompanied by increased expression of FoxP3 mRNA and IL-10 production, and decreased IL-17 secretion and STAT3 phosphorylation in purified CD4(+) T cells. Moreover, IL-35 stimulation inhibited viral specific Th17-like phenotype differentiation from Tregs in CHB patients. Effective anti-HBV therapy did not affect viral specific Tregs/Th17 cells frequency or IL-35 expression in CHB patients, however, reduced responsiveness of CD4(+) T cells or Tregs to IL-35 stimulation in vitro. CONCLUSION: Our findings indicated that IL-35 regulation to viral specific Tregs/Th17 balance may contribute to viral persistence in chronic HBV infection. BioMed Central 2019-04-16 /pmc/articles/PMC6469219/ /pubmed/30992023 http://dx.doi.org/10.1186/s12985-019-1158-0 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Yang, Lanlan Jia, Shengnan Shao, Xue Liu, Siqi Zhang, Qian Song, Jie Wang, Wudong Jin, Zhenjing Interleukin-35 modulates the balance between viral specific CD4(+)CD25(+)CD127(dim/-) regulatory T cells and T helper 17 cells in chronic hepatitis B virus infection |
title | Interleukin-35 modulates the balance between viral specific CD4(+)CD25(+)CD127(dim/-) regulatory T cells and T helper 17 cells in chronic hepatitis B virus infection |
title_full | Interleukin-35 modulates the balance between viral specific CD4(+)CD25(+)CD127(dim/-) regulatory T cells and T helper 17 cells in chronic hepatitis B virus infection |
title_fullStr | Interleukin-35 modulates the balance between viral specific CD4(+)CD25(+)CD127(dim/-) regulatory T cells and T helper 17 cells in chronic hepatitis B virus infection |
title_full_unstemmed | Interleukin-35 modulates the balance between viral specific CD4(+)CD25(+)CD127(dim/-) regulatory T cells and T helper 17 cells in chronic hepatitis B virus infection |
title_short | Interleukin-35 modulates the balance between viral specific CD4(+)CD25(+)CD127(dim/-) regulatory T cells and T helper 17 cells in chronic hepatitis B virus infection |
title_sort | interleukin-35 modulates the balance between viral specific cd4(+)cd25(+)cd127(dim/-) regulatory t cells and t helper 17 cells in chronic hepatitis b virus infection |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469219/ https://www.ncbi.nlm.nih.gov/pubmed/30992023 http://dx.doi.org/10.1186/s12985-019-1158-0 |
work_keys_str_mv | AT yanglanlan interleukin35modulatesthebalancebetweenviralspecificcd4cd25cd127dimregulatorytcellsandthelper17cellsinchronichepatitisbvirusinfection AT jiashengnan interleukin35modulatesthebalancebetweenviralspecificcd4cd25cd127dimregulatorytcellsandthelper17cellsinchronichepatitisbvirusinfection AT shaoxue interleukin35modulatesthebalancebetweenviralspecificcd4cd25cd127dimregulatorytcellsandthelper17cellsinchronichepatitisbvirusinfection AT liusiqi interleukin35modulatesthebalancebetweenviralspecificcd4cd25cd127dimregulatorytcellsandthelper17cellsinchronichepatitisbvirusinfection AT zhangqian interleukin35modulatesthebalancebetweenviralspecificcd4cd25cd127dimregulatorytcellsandthelper17cellsinchronichepatitisbvirusinfection AT songjie interleukin35modulatesthebalancebetweenviralspecificcd4cd25cd127dimregulatorytcellsandthelper17cellsinchronichepatitisbvirusinfection AT wangwudong interleukin35modulatesthebalancebetweenviralspecificcd4cd25cd127dimregulatorytcellsandthelper17cellsinchronichepatitisbvirusinfection AT jinzhenjing interleukin35modulatesthebalancebetweenviralspecificcd4cd25cd127dimregulatorytcellsandthelper17cellsinchronichepatitisbvirusinfection |